NCT00309062已完成3 期
A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of Immunotherapy With an Aluminium Hydroxide-adsorbed Recombinant Hypoallergenic Derivative of the Major Birch Pollen Allergen, Bet v 1
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
Safety and efficacy of recombinant birch pollen allergen in the treatment of allergic rhinoconjunctivitis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Positive Skin Prick Test reaction to birch pollen
- •Positive RAST result to birch pollen
- •Positive Provocation Test result to birch pollen
排除标准
- •Serious chronic diseases
- •Other perennial allergies
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o AsthmaBirch Pollen AllergyAllergic RhinoconjunctivitisNCT05668390Stallergenes Greer553
已完成
3 期
Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic RhinoconjunctivitisGrass Pollen AllergyNCT00263601Allergopharma GmbH & Co. KG154
已完成
3 期
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic RhinitisAllergic ReactionAllergic RhinitisNCT03157505Medical University of Silesia78
已完成
3 期
Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic RhinoconjunctivitisAllergyNCT00309036Allergopharma GmbH & Co. KG
Unknown
4 期
Can we Help People With the Oral Allergy Syndrome Eat Fresh Fruit?Oral Allergy SyndromeNCT01431859Royal Sussex County Hospital40